TY  - GEN
AU  - Deyà-Martínez, Angela
AU  - Rivière, Jaques G
AU  - Roxo-Junior, Pérsio
AU  - Ramakers, Jan
AU  - Bloomfield, Markéta
AU  - Guisado Hernandez, Paloma
AU  - Blanco Lobo, Pilar
AU  - Abu Jamra, Soraya Regina
AU  - Esteve-Sole, Ana
AU  - Kanderova, Veronika
AU  - García-García, Ana
AU  - Lopez-Corbeto, Mireia
AU  - Martinez Pomar, Natalia
AU  - Martín-Nalda, Andrea
AU  - Alsina, Laia
AU  - Neth, Olaf
AU  - Olbrich, Peter
PY  - 2022
DO  - 10.1007/s10875-022-01257-x
UR  - https://hdl.handle.net/20.500.12105/23455
AB  - Introduction: Since the first description of gain of function (GOF) mutations in signal transducer and activator of transcription (STAT) 1, more than 300 patients have been described with a broad clinical phenotype including infections and severe...
LA  - eng
KW  - Baricitinib
KW  - Chronic mucocutaneous candidiasis
KW  - Inborn errors of immunity
KW  - JAK inhibitors
KW  - JAK-STAT pathway
KW  - Primary immunodeficiency disease
KW  - Ruxolitinib
KW  - STAT1 GOF
TI  - Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature
TY  - research article
ER  -